Posted on April 27, 20234/27/23
European Commission’s Long-awaited Pharma Legislation Review Gets Mixed Reception
Posted on April 21, 20234/21/23
Left-Right-Left: The Latest in Pharma-Payer Ping Pong
Posted on April 20, 20234/20/23
Your Guide to Developing a Best-in-Class Specialty Pharmacy Network Strategy
Posted on April 13, 20234/13/23
Peeking Behind the PBM-lead GPO Curtain
Posted on November 22, 202211/22/22
Ready or Not, Biosimilar Adalimumab Brings the Heat in 2023
Posted on November 16, 202211/16/22
Case Study: Benchmarking Pathway-Specific Engagement with Health Plans & Organized Providers to Identify Best Practices
Posted on November 3, 202211/3/22
Payer Oncology Access Management in 2022
Posted on December 21, 202112/21/21
Launch Sequencing and Market Prioritization in an Evolving Global Market
Posted on April 9, 20214/9/21